Advancing Sustainable Agriculture - Interview with Nina Vinot on the Role of Microbiome Innovations In a recent interview, Nina Vinot, Director of Business Development at Cybele Agrocare, and Business Development, Bioprox Healthcare, discussed with Muhammad Younis how innovations in microbiome science are transforming agriculture.
Emirate Leads in Sustainable Growth with Record Non-Oil GDP, Green FDI Ranking –UAE Ministry of Economy Ras Al Khaimah, December 12: At the Ras Al Khaimah Investment and Business Summit, held on December 10th and 11th at the Al Hamra International Exhibition & Conference Center, H.
RAKIS 2024 Concludes with Visionary Strategies for RAK’s Future Growth Ras Al Khaimah, December 11: The second day of the Ras Al Khaimah Investment and Business Summit (RAKIS 2024) continued to shape the emirate’s economic future, featuring thought-provoking discussions
‘2024-2027 are Pivotal Years for Investment Growth in Ras Al Khaimah’- RAKIS Day 1 Ras Al Khaimah, December 10: The inaugural edition of Ras Al Khaimah Investment and Business Summit (RAKIS) opened to a resounding start at the Al Hamra International Exhibition & Conference
#LBS25 to Spotlight Advancements in Pharmaceutical Biotechnology, Digital Health, Medical Devices, Advanced Therapies, and More London, December 10: The second edition of the London Biotechnology Show (#LBS) continues to elevate its prestige with each passing day, as more renowned speakers and leading exhibitors join the
RAKIS 2024 Opens Doors to Transformative Investment in Ras Al Khaimah Ras Al Khaimah, December 10: The wait is over as the much-anticipated Ras Al Khaimah Investment and Business Summit (RAKIS) opens its doors today at the prestigious Al Hamra International
7 Days Left: RAKIS Ready to Shape Future of Investment in Ras Al Khaimah Ras Al Khaimah, December 2: The much anticipated Ras Al Khaimah Investment and Business Summit is only a week away. Set to take place at Al Hamra International Exhibition &
London EV Show 2024 Concludes: Sets New Benchmark in Electric Mobility Discussions London, November 28: The fourth edition of London EV Show wrapped up today, delivering a strong message of collaboration, innovation, and progress towards a sustainable, electric future. Held at ExCeL
#CTS24 Concludes: Paves Way to Cleaner Planet with Net-Zero and Sustainable Solutions London, November 28: The 3rd edition of the London Climate Technology Show concluded today, paving a vital roadmap towards fully decarbonising our planet through sustainable technologies. The event brought together
Driving Climate Action: Third Edition of London Climate Technology Show Commences Today London, November 27: The wait is over as the third edition of London Climate Technology Show opens its doors at ExCeL London, uniting global leaders, innovators, and changemakers to drive
London EV Show: Day 1 Paves Way for Greener, Electric Future London, November 26: The London EV Show 2024 officially kicked off today with immense energy, unveiling groundbreaking innovations that highlight London’s crucial role in driving the global electric mobility
London EV Show Goes Live: Future of Mobility on Display London, November 26: The fourth edition of the London EV Show has officially opened its doors at ExCeL London, bringing together a powerful assembly of influential thought leaders, industry pioneers,
Two Weeks to Go: London Climate Technology Show Poised to Revolutionise Sustainable Innovation London, November 13: The London Climate Technology Show 2024 is just 14 days away, bringing together industry experts, business leaders, and influential decision-makers at ExCeL London to chart the course
13 Days Remain To Register For London EV Show, Connect with Industry Titans London, November 13: Anticipation is mounting as the fourth edition of the London EV Show draws closer, now just 13 days away. From November 26-28, 2024, ExCeL London is set
Interview with Behzad Mahdavi, Executive Chairman at OpenCell Technologies: Insights on Gene Therapies, Challenges and Solutions Gene therapy offers groundbreaking possibilities for treating genetic disorders, yet its journey to mainstream clinical use is hindered by key obstacles, involving safety, efficacy, delivery, and high manufacturing costs. In
